|
|
Volumn 7, Issue 3, 2017, Pages 241-242
|
|
DLBCL Responds Well to Anti-CD19 CAR Therapy
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD19 ANTIGEN;
CD19 MOLECULE, HUMAN;
DIFFUSE LARGE B CELL LYMPHOMA;
HUMAN;
METABOLISM;
MULTICENTER STUDY (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
T LYMPHOCYTE;
TRANSPLANTATION;
TREATMENT OUTCOME;
ANTIGENS, CD19;
CLINICAL TRIALS, PHASE II AS TOPIC;
HUMANS;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
MULTICENTER STUDIES AS TOPIC;
T-LYMPHOCYTES;
TREATMENT OUTCOME;
|
|
EID: 85038369571
PISSN: None
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2017-009 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|